Papillomavirus polyprotein constructs
US6365160B1 · kind B1 · utility
Assignees
Inventors
Key dates
| Filing date | Apr 21, 1998 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | Apr 21, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides, antibodies and recombinant expression systems or cells that contain and express a DNA insert of HPV encoding a region of a papilloma induced or a papilloma protein, such as E6 or E7, are produced. Compositions containing these peptides, antibodies and/or recombinant cells are utilized as immunogenic compositions and in methods for inhibiting and treating HPV infection and tumor initiation and progression. Specific peptides and recombinant cells, such as vaccinia virus and tumor cells, that express epitopic regions of the HPV16 E6 or E7 nucleoprotein are particularly described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.